NDC 0074-1824 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0074-1824
- Package NDCs from labels
- 0074-1824-30
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0074-1824-30 | Novocain | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 0074-1824-30 | Novocain | 100 in 1 CASE | INJECTION, SOLUTION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | a99fe500-f52b-483c-807c-178f1a78a02b | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-07-15 | Warnings, Adverse reactions | Sodium Chloride |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | Hospira, Inc. |
| Lorazepam | LORAZEPAM | Hospira, Inc. | 20140b19-846b-425f-b191-670e17809945 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Hospira, Inc. | 1c993365-1b62-4524-e781-d307f28f63bc | 2026-07-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Procainamide Hydrochloride | PROCAINAMIDE HYDROCHLORIDE | Hospira, Inc. | 17e47845-daad-434c-a784-6d3875b0d704 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Paclitaxel | PACLITAXEL | Hospira, Inc. | ea28753a-8631-460a-bfdc-b101eb8ac84a | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Nipent | PENTOSTATIN | Hospira, Inc. | 674e0e6d-46ed-4868-9196-04019d667716 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Hospira, Inc. | 559a0a8c-a8fe-40a5-b196-21f9308780ab | 2026-07-01 | Warnings, Adverse reactions | Hospira, Inc. |
| CHROMIUM | CHROMIC CHLORIDE | Hospira, Inc. | b4d01ebb-a36e-44b7-028c-43c0ab2d13b4 | 2026-06-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Chromium | CHROMIC CHLORIDE | Hospira, Inc. | da207ca8-7836-4c66-92fe-36cc89baf773 | 2026-06-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Marcaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | 2026-06-23 | Warnings, Adverse reactions | Hospira, Inc. |
| Linezolid | LINEZOLID | Hospira, Inc. | c401f1a8-cc37-461b-bfef-f2e156629bf8 | 2026-06-19 | Warnings, Adverse reactions | Hospira, Inc. |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 92b7ddaa-e45a-4b64-a802-bb5df8771dd6 | 2026-06-17 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Cardinal Health 107, LLC | 107af8bc-b6af-4b85-8c8a-ea757dcef1da | 2026-06-12 | Adverse reactions | Sodium Chloride |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 4419162d-81d4-49bd-96de-1729440bdb74 | 2026-06-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Dobutamine in Dextrose | DOBUTAMINE IN DEXTROSE | Hospira, Inc. | 9943a961-3b50-4847-8a84-d8414ce38daa | 2026-06-03 | Warnings, Adverse reactions | Hospira, Inc. |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | Hospira, Inc. |
| Sufentanil Citrate | SUFENTANIL CITRATE | Hospira, Inc. | 20293943-46ff-4345-1aa4-929b4e017a25 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.